Features

Learn how fetal analgesia is used to minimize pain or discomfort for a fetus during an intrauterine transfusion due to HDFN.

Learn about what to expect after delivery for your newborn affected by HDFN and what resources are available to help.

Maternal antibodies can cross the placenta at any time following alloimmunization, but it occurs mostly in the second or third trimester.

Testing of an infant’s father in addition to the standard prenatal screening of the mother can more accurately identify the risk of HDFN.

Learn about why an iron transfusion may be necessary to treat HDFN and what to expect if your doctor recommends one.

IVIG is a common treatment for HDFN, and though most side effects are mild, there is a small risk of serious complications.

Some vaccines aren’t safe for pregnant women, and IVIG may cause certain vaccines to become less effective following treatment.

Learn more about why induction may be recommended in your HDFN-affected pregnancy and what to expect if you are induced.

Learn more about the similarities and differences between fetal and neonatal alloimmune thrombocytopenia (FNAIT) and HDFN.

Learn about who can make decisions during or after labor and delivery if you are unable and how to prepare for this ahead of time.